Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › AAV-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells

AAV-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells

US Patent 12343408 · Granted Jul 1, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Identification of mutations in channelopsin variants having improved light sensi2025
Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids2024
Modified mGluR6 promoter and methods of use2023
Identification of mutations in channelopsin variants having improved light sensi2021
Identification of channelrhodopsin-2 (ChR2) mutations and methods of use2021
Modified MGLUR6 promoter and methods of use2019
AAV-mediated subcellular targeting of heterologous rhodopsins in retinal ganglio2018
Method of enhancing delivery of therapeutic compounds to the eye2017
Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids2017
AAV-mediated subcellular targeting of heterologous rhodopsins in retinal ganglio2016
Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids2013